Most recently, ILiAD Biotechnologies raised $115.0M in its Later Stage VC (Series B) (Feb 2026).
- ·The complete investor list: 11 names
- ·Watch ILiAD Biotechnologies: the Monday email on marks, rounds and moves
ILiAD Biotechnologies round by round
7 roundsHow much has ILiAD Biotechnologies raised?
ILiAD Biotechnologies has raised $215 million across 7 recorded rounds since 2017. The largest was a $675,220 seed round in Jan 2018; the most recent was an $115 million Series B in Feb 2026.
ILiAD Biotechnologies has filed 11 Form Ds with the SEC since 2017, most recently in Feb 2026 ($116 million sold to 36 investors).
ILiAD Biotechnologies investors
11 investors are on record for ILiAD Biotechnologies, including RA Capital Management, National Institutes of Health, European Union and BNP Paribas Asset Management. The Series B in Feb 2026 drew 2 investors.
11 investors have backed ILiAD Biotechnologies — start your target list with the firms already writing checks in drug discovery.
Frequently asked about ILiAD Biotechnologies
- How much has ILiAD Biotechnologies raised?
- ILiAD Biotechnologies has raised $214.6M in total across 7 recorded funding rounds.
- When was ILiAD Biotechnologies's last funding round?
- ILiAD Biotechnologies's most recent recorded round was Later Stage VC (Series B) in Feb 2026, raising $115.0M.